1991
DOI: 10.1016/0196-9781(91)90120-e
|View full text |Cite
|
Sign up to set email alerts
|

Structure, bioactivity, and cellular localization of myomodulin B: A novel Aplysia peptide

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

2
50
0
2

Year Published

1994
1994
2005
2005

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 51 publications
(54 citation statements)
references
References 9 publications
2
50
0
2
Order By: Relevance
“…1, right; for review and complete references see Brezina et al 2003aBrezina et al , 2005Hooper et al 1999;Kupfermann et al 1997;Weiss et al 1993). Most important are the small cardioactive peptides (SCPs), released from motor neuron B15 (e.g., Cropper et al 1987a;Lloyd et al 1984;Vilim et al 1996b), and the myomodulins (MMs), released from motor neuron B16 Cropper et al 1987bCropper et al , 1991Vilim et al 2000). The SCPs and MMs shape contractions through three main effects on the muscle: 1) they potentiate the contractions by enhancing the muscle's depolarization-activated Ca current that supplies Ca 2ϩ essential for contraction (e.g., Brezina et al 1994a; 2) they depress the contractions by activating in the muscle a K current that opposes the ACh-induced depolarization, activation of the Ca current, and Ca 2ϩ influx (Brezina et al 1994bOrekhova et al 2003); and 3) they increase the relaxation rate of the contractions probably by modulating the muscle's contractile machinery (Heierhorst et al , 1995Probst et al 1994).…”
Section: Introductionmentioning
confidence: 99%
“…1, right; for review and complete references see Brezina et al 2003aBrezina et al , 2005Hooper et al 1999;Kupfermann et al 1997;Weiss et al 1993). Most important are the small cardioactive peptides (SCPs), released from motor neuron B15 (e.g., Cropper et al 1987a;Lloyd et al 1984;Vilim et al 1996b), and the myomodulins (MMs), released from motor neuron B16 Cropper et al 1987bCropper et al , 1991Vilim et al 2000). The SCPs and MMs shape contractions through three main effects on the muscle: 1) they potentiate the contractions by enhancing the muscle's depolarization-activated Ca current that supplies Ca 2ϩ essential for contraction (e.g., Brezina et al 1994a; 2) they depress the contractions by activating in the muscle a K current that opposes the ACh-induced depolarization, activation of the Ca current, and Ca 2ϩ influx (Brezina et al 1994bOrekhova et al 2003); and 3) they increase the relaxation rate of the contractions probably by modulating the muscle's contractile machinery (Heierhorst et al , 1995Probst et al 1994).…”
Section: Introductionmentioning
confidence: 99%
“…B15 releases, in particular, the small cardioactive peptides (SCPs) (Cropper et al 1987a(Cropper et al , 1990aLloyd et al 1984;Vilim et al 1996a;Whim and Lloyd 1989), and B16 releases the myomodulins (MMs) Cropper et al 1987bCropper et al , 1991Vilim et al 2000). The SCPs and MMs shape contractions through 3 main actions on the muscle: 1) they potentiate the contractions by enhancing the muscle's depolarization-activated Ca current that supplies Ca 2ϩ essential for contraction Brezina et al 1994aCropper et al 1987aCropper et al ,b, 1991Lloyd et al 1984;Whim and Lloyd 1990;); 2) they depress the contractions by activating in the muscle a K current that opposes the ACh-induced depolarization, activation of the Ca current, and Ca 2ϩ influx (Brezina et al 1994bCropper et al 1987bCropper et al , 1991; and 3) they increase the relaxation rate of the contractions probably by modulating the muscle's contractile machinery Cropper et al 1990a;Heierhorst et al 1995;Probst et al 1994;Whim and Lloyd 1990). The balance of the competing potentiating and depressing actions determines the net modulation of contraction size, which, together with the modulation of the relaxation rate, then gives the final shape of the contraction (see Brezina et al 2000a).…”
Section: Introductionmentioning
confidence: 99%
“…An important example of this structural diversity is the myomodulin family of molluscan neuropeptides. Myomodulin A (PMSMLRLamide) and eight related peptides were first discovered by molecular and biochemical methods in Aplysia (Cropper et al, 1987(Cropper et al, , 1991Lopez et al, 1993;Miller et al, 1993;Brezina et al, 1995). Myomodulin A is now known to be present in several other molluscs together with at least one more related molecule (Fugisawa et al, 1990), and further types of myomodulin are also likely to be discovered with further investigation.…”
mentioning
confidence: 99%
“…Studies aimed at understanding the signaling function of neuropeptides have emphasized the value of using model invertebrate systems, such as gastropod molluscs, in which the pattern of gene expression and the physiological function of processed peptides can be studied at the level of single identified neurons (Cropper et al, 1987(Cropper et al, , 1991Benjamin and Burke, 1994). A common feature of invertebrate neuropeptide genes is that they encode a variety of structurally related peptides present on one or more precursor proteins.…”
mentioning
confidence: 99%